Bayer using Accenture’s AI tool to accelerate drug development

By Vassia Barba

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags Accenture Data management Clinical data Bayer

Bayer collaborates with Accenture on the Intient clinical platform, which integrates internal and external clinical data to accelerate drug development insights.

Accenture Life Sciences, a technology consulting firm, announced that its artificial intelligence​ (AI) clinical data collection and management tool, Intient, is being used by Bayer.

The platform, which went live at Bayer earlier this year, uses cloud-based technology developed by Oracle to enable the collection of internal and external clinical data​ into a single data management and storage platform.

As a result, Intient has the potential to create actionable insights to accelerate drug development and improve patient outcomes.

Under the collaboration agreement between Bayer and Accenture, the former company has also joined the Life Sciences Cloud Coalition​, a group of businesses built by Accenture and Oracle, to link biopharmaceutical companies willing to share their clinical data.

A spokesperson for Accenture told us “With the addition of Bayer, we have already seen a resounding commitment to collaboration with their peers in industry.”

“Bayer brings a global, patient-centric approach to their clinical development processes and have been transparent in their sharing of processes and best practices,”​ the spokesperson added.

Members of the Life Sciences Cloud Coalition include Pfizer, Eli Lilly, Bayer, Merck, Novo Nordisk and GlaxoSmithKline.

The aim of the coalition, according to Accenture, is to enable ‘pre-competitive’ collaboration between companies and support quick and cost-effective advancement of clinical development.

“The future of R&D is bright when leading organizations come together to solve for patients’ greatest needs,”​ commented Mike Stapleton, a managing director in Accenture’s Life Sciences practice.

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars